This article was originally published with errors in four of the 29 sequences used to perform the in vitro measurement, requiring minor corrections to the main text, figure 1, table 1 and the supplementary material. These have now been corrected in the article itself. The authors apologise for this error.
. 2018 Jul 13;4(3):00080-2017-AUT. doi: 10.1183/23120541.50080-2017
“Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons” Iwona Pranke, Laure Bidou, Natacha Martin, Sandra Blanchet, Aurélie Hatton, Sabrina Karri, David Cornu, Bruno Costes, Benoit Chevalier, Danielle Tondelier, Emmanuelle Girodon, Matthieu Coupet, Aleksander Edelman, Pascale Fanen, Olivier Namy, Isabelle Sermet-Gaudelus and Alexandre Hinzpeter. ERJ Open Res 2018; 4: 00080-2017.
Collection date 2018 Jul.
Copyright ©ERS 2018
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
PMCID: PMC6048687 PMID: 30035115
This corrects the article "Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons", 00080-2017.